Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsProphylactic antibiotics for burns patients: systematic review and meta-analysisDNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureusVancomycin-resistant Staphylococcus aureus isolate from a patient in PennsylvaniaClinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching HospitalMicrobiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian HospitalsCarriage frequency, phenotypic and genotypic characteristics of Staphylococcus aureus isolated from dialysis and kidney tranplant patients at a hosptial in northern paraná.Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, IranGenetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern IranVancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.First report of vancomycin-resistant staphylococci isolated from healthy carriers in BrazilGenetic similarity between staphylococcus sp isolated from human and hospital settings, and susceptibility to different antimicrobials.walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.Evaluation of methods in detecting vancomycin MIC among MRSA isolates and the changes in accuracy related to different MIC values.Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria.
P2860
Q24646677-44E546A8-2904-4838-891D-D1F4BDF61B40Q24647459-BF2BBB13-A53E-4E0D-849C-633472E9517FQ33220466-9CB41CA9-05F1-45E8-A2D8-99B0DE217FE9Q34396414-798DF31C-00A1-4053-A409-63C68169F4D8Q34596835-783C5401-BC75-4B8A-A2A5-CECEE3102676Q34747322-6A7B81F4-5011-4017-A243-27F782541EA8Q35007120-459D6774-AD10-4C12-8952-9C453282123DQ36116970-0EB0897E-C895-4CC2-8B49-E325EC956FC4Q36328966-971C6903-2B7F-4BC5-A96A-15330056C438Q36779557-AD2DFC26-39CC-40CD-9EFA-6F78E04F4F4BQ36876054-E3C0C415-8D7E-4389-9160-B29FC33BC1C7Q37160040-E0E4CDCD-D17E-494B-8491-7491A0FA3FACQ37335734-0F075C48-902F-4AA4-8D9C-BBA587F0FC9CQ38602186-5C2E446A-4B33-48FD-91AE-F98FA5F00475Q39561287-10B817C3-882A-4672-88E6-9011E8F465FFQ40113831-DDE8E6AE-F19E-4D07-8FDE-33CFCD4F3F73Q40771872-F42BB611-DAC9-4701-BD43-DEE23A454215Q42075853-BEA5740D-6651-4494-A30C-7C31A4FAFDF3Q42110968-914E5C4C-97BF-44DA-A49E-9C987488E909Q42112516-57D23030-81BC-4242-ACF3-5D4365D12FFAQ43108718-86A7F5C0-20A2-4EFD-8008-1EF4E2D4DBD6Q47113424-B6AEF336-4BBB-4EFA-83D1-CEF677F699E9
P2860
Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@en
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@nl
type
label
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@en
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@nl
prefLabel
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@en
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@nl
P2093
P2860
P356
P1476
Isolation in Brazil of nosocom ...... susceptibility to vancomycin.
@en
P2093
A M Dell'Aquila
E M Mamizuka
G A Oliveira
K Hiramatsu
R L Masiero
P2860
P304
P356
10.1086/501932
P577
2001-07-01T00:00:00Z